摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-cyclohexyl-2,3,4,5-tetrahydro-pyridine | 56528-76-8

中文名称
——
中文别名
——
英文名称
6-cyclohexyl-2,3,4,5-tetrahydro-pyridine
英文别名
6-Cyclohexyl-2,3,4,5-tetrahydro-pyridin;6-Cyclohexyl-2,3,4,5-tetrahydropyridine
6-cyclohexyl-2,3,4,5-tetrahydro-pyridine化学式
CAS
56528-76-8
化学式
C11H19N
mdl
——
分子量
165.279
InChiKey
BOBAWHZJROUFFM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    246.0±9.0 °C(Predicted)
  • 密度:
    1.05±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.91
  • 拓扑面积:
    12.4
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    6-cyclohexyl-2,3,4,5-tetrahydro-pyridine 在 sodium tetrahydroborate 作用下, 以 甲醇 为溶剂, 以50 mg的产率得到2-环己基哌啶
    参考文献:
    名称:
    A One-Pot Process for the Enantioselective Synthesis of Amines via Reductive Amination under Transfer Hydrogenation Conditions
    摘要:
    Cyclic amines may be prepared via a sequence of deprotection followed by intramolecular reductive amination of t-Boc-protected amino ketones under asymmetric transfer hydrogenation conditions. In cases where the corresponding imine reaction proceeds with high enantioselectivity, this is reflected in the one-step process.
    DOI:
    10.1021/ol035746r
  • 作为产物:
    描述:
    哌啶酮正丁基锂magnesium三氟乙酸 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 反应 3.0h, 生成 6-cyclohexyl-2,3,4,5-tetrahydro-pyridine
    参考文献:
    名称:
    A One-Pot Process for the Enantioselective Synthesis of Amines via Reductive Amination under Transfer Hydrogenation Conditions
    摘要:
    Cyclic amines may be prepared via a sequence of deprotection followed by intramolecular reductive amination of t-Boc-protected amino ketones under asymmetric transfer hydrogenation conditions. In cases where the corresponding imine reaction proceeds with high enantioselectivity, this is reflected in the one-step process.
    DOI:
    10.1021/ol035746r
点击查看最新优质反应信息

文献信息

  • Synthesis of Tetrazole-Derived Organocatalysts via Azido-Ugi Reaction with Cyclic Ketimines
    作者:Olga I. Shmatova、Valentine G. Nenajdenko
    DOI:10.1021/jo401428q
    日期:2013.9.20
    A new route to tetrazole-derived cyclic amines based on the TMSN3-modified Ugi reaction with 2-substituted cyclic imines was elaborated. The reaction allows the direct preparation of five-, six-, and seven-membered cyclic amines substituted with a tetrazole ring, which are important types of organocatalysts. The scope and limitations of this method are discussed. In the case of the Ugi reaction with
    基于TMSN 3的四唑衍生环胺的新途径阐述了用2-取代的环状亚胺进行的修饰的Ugi反应。该反应允许直接制备被四唑环取代的五元,六元和七元环胺,这是重要的有机催化剂类型。讨论了该方法的范围和局限性。在Ugi与苄基化物反应的情况下,N-取代的四唑可以在催化化条件下容易地苄基,以定量收率形成NH-四唑。证明了四唑衍生的环胺的两种对映体都可以通过酒石酸拆分而制备,从而引发了一种简单的手性衍生物路线。在胺化反应中,将获得的手性四唑之一有效地用作有机催化剂
  • Six-Component Azido-Ugi Reaction: from Cyclic Ketimines to Bis-Tetrazole-Derived 5-7-Membered Amines
    作者:Irina V. Kutovaya、Danil P. Zarezin、Olga I. Shmatova、Valentine G. Nenajdenko
    DOI:10.1002/ejoc.201900244
    日期:2019.4.24
    The six‐component azido‐Ugi reaction with 2‐substituted 5–7‐membered imines leads to mono‐ or bis‐tetrazole derivatives depending on the starting imines. The reaction is very general regarding isocyanide structure and enables preparation of 1,5‐disubstituted bis‐tetrazole derivatives connected with 5–7‐membered cyclic amine fragments. Subsequent catalytic debenzylation provides the corresponding 1H‐tetrazoles
    与2个取代的5-7元亚胺形成的六组分叠氮基-Ugi反应取决于起始的亚胺,生成单或双四唑生物。关于异氰酸酯的结构,该反应非常笼统,可制备与5-7元环胺片段连接的1,5-二取代双-四唑生物。随后的催化苄基作用提供了相应的1H-四唑
  • An (<i>R</i>)-Imine Reductase Biocatalyst for the Asymmetric Reduction of Cyclic Imines
    作者:Shahed Hussain、Friedemann Leipold、Henry Man、Elizabeth Wells、Scott P. France、Keith R. Mulholland、Gideon Grogan、Nicholas J. Turner
    DOI:10.1002/cctc.201402797
    日期:2015.2
    enantiomerically pure chiral amines continues to expand, few existing methods provide access to secondary amines. To address this shortcoming, we have over-expressed the gene for an (R)-imine reductase [(R)-IRED] from Streptomyces sp. GF3587 in Escherichia coli to create a recombinant whole-cell biocatalyst for the asymmetric reduction of prochiral imines. The (R)-IRED was screened against a panel of cyclic imines
    尽管可用于合成对映体纯的手性胺的生物催化剂的范围不断扩大,但现有的方法很少能提供仲胺的途径。为了解决这个缺点,我们过量表达了链霉菌属(Streptomyces sp。)的(R)-亚胺还原酶[(R)-IRED]的基因。GF3587在大肠杆菌中创建重组全细胞生物催化剂,用于不对称还原前手性亚胺。针对一组环状亚胺和两个亚胺离子筛选了(R)-IRED,结果显示该催化剂具有较高的催化活性和对映选择性。从亚胺前体的制备规模的生物碱(R)-亚酸的合成规模(90%收率; 99%ee)以克为单位进行。酶活性位点的同源模型,基于来自链霉菌的紧密相关的(R)-IRED的结构,
  • Transformation of cyclic ketimines to oxaziridines and nitrones
    作者:Natalia G. Voznesenskaia、Olga I. Shmatova、Valentine G. Nenajdenko
    DOI:10.1016/j.mencom.2017.01.008
    日期:2017.1
    Treatment of 5-, 6- and 7-membered cyclic ketimines bearing alkyl or aryl group with m-chloroperbenzoic acid proceeds as C=N epoxidation and affords bicyclic oxaziridines in good yields, whose subsequent rearrangement gives nitrones.
    用间苯甲酸处理带有烷基或芳基的5-,6-和7-元环状亚胺,以C = N环化的方式进行,并以良好的收率得到双环恶唑烷,其随后的重排产生了硝
  • From Cyclic Ketimines to α‐Substituted Cyclic Amino Acids and their Derivatives: Influence of Ring Size and Substituents on Stability and Reactivity of Cyclic Aminonitriles
    作者:Natalia G. Voznesenskaia、Olga. I. Shmatova、Anna A. Sosnova、Valentine G. Nenajdenko
    DOI:10.1002/ejoc.201801087
    日期:2019.1.31
    A general route to alpha‐substituted cyclic amino acids was elaborated. The approach is based on Strecker reaction with cyclic ketimines. The series of 5–7 membered amino nitriles having different substituents were prepared. Synthesis of alpha‐substituted prolines and their amides was elaborated starting from the corresponding 5‐membered ketimines
    阐述了获得α-取代的环状氨基酸的一般途径。该方法基于与环亚胺的斯特雷克反应。制备了一系列具有不同取代基的5-7元基腈。从相应的五元亚胺开始详细阐述了α-取代的脯酸及其酰胺的合成
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S,2'S)-(-)-[N,N'-双(2-吡啶基甲基]-2,2'-联吡咯烷双(乙腈)铁(II)六氟锑酸盐 (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 (1'R,2'S)-尼古丁1,1'-Di-N-氧化物 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸氯苯那敏-D6 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 韦德伊斯试剂 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非布索坦杂质66 非尼拉朵 非尼拉敏 雷索替丁 阿雷地平 阿瑞洛莫 阿扎那韦中间体 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 镉,二碘四(4-甲基吡啶)- 锌,二溴二[4-吡啶羧硫代酸(2-吡啶基亚甲基)酰肼]-